Maharishi Arvind Institute of Pharmacy, Jaipur, Rajasthan India.
Received on 26 October 2022; revised on 12 December 2022; accepted on 14 December 2022
Gastroesophageal reflux disease (GERD) is a chronic disorder of the upper gastrointestinal tract with global distribution. The incidence is on the increase in different parts of the world. It is characterized by heartburn and/or regurgitation symptoms is one of the most common gastrointestinal disorders managed by gastroenterologists and primary care physicians. Optimization of therapy (improving compliance and timing of PPI doses), or increasing PPI dosage to twice daily in select circumstances, can reduce persistent symptoms. In patients with residual reflux, medications like H2 blockers, Prokinetics and baclofen may be used. In those with functional heartburn or reflux sensitivity neuro-modulators form an integral part of any therapeutic approach.
Gastroesophageal reflux; Proton pump inhibitors; Prokinetics; Esophageal; Management
Get Your e Certificate of Publication using below link
Preview Article PDF
Pooja Rani, Rajesh Asija and Rashmi Khanijau. Review on management of GERD. World Journal of Biology Pharmacy and Health Sciences, 2022, 12(03), 216-223. Article DOI: https://doi.org/10.30574/wjbphs.2022.12.3.0232